SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-20-000026
Filing Date
2020-05-07
Accepted
2020-05-07 07:03:16
Documents
16
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-q1x2020pressrelease.htm   iXBRL 8-K 53125
2 EXHIBIT 99.1 ex991-q1x2020.htm EX-99.1 579083
8 GRAPHIC bauschlogoa08.jpg GRAPHIC 7860
  Complete submission text file 0000885590-20-000026.txt   832698

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20200507.xsd EX-101.SCH 4447
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20200507_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20200507_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20200507_lab.xml EX-101.LAB 27205
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20200507_pre.xml EX-101.PRE 14099
12 EXTRACTED XBRL INSTANCE DOCUMENT a8k-q1x2020pressrelease_htm.xml XML 4598
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 20854516
SIC: 2834 Pharmaceutical Preparations